<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.head-face-med.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Head &amp; Face Medicine - Latest Articles</title>
        <link>http://www.head-face-med.com</link>
        <description>The latest research articles published by Head &amp; Face Medicine</description>
        <dc:date>2010-03-11T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/6/1/3" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/6/1/2" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/6/1/1" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/27" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/26" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/25" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/24" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/23" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/22" />
                                <rdf:li rdf:resource="http://www.head-face-med.com/content/5/1/21" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.head-face-med.com/content/6/1/3">
        <title>Control of mandibular incisors with the combined Herbst and completely customized lingual appliance - a pilot study</title>
        <description>Background:
The traditional Herbst appliance induces mandibular incisor proclination independent of the anchorage system used. The dental effects of the Herbst appliance as an element of a completely customized lingual orthodontic (LO) appliance (Incognito, 3 M) has not been analyzed yet and the aim of this paper was to measure the effect of mandibular incisor proclination using this Herbst-LO device.
Methods:
Retrospective study. Inclusion criteria: a) Class II &#8805; 5 mm molar relationship; b) Herbst appliance &#8805; 9 months in situ; and c) finished active treatment. Incisor position was measured on digital models before treatment, on the digital target setup, and on digital models obtained at the day of debonding. All measurements were performed by one investigator.
Results:
Twelve patients (8 females, 4 males) out of 632 cases treated with a lingual appliance were included in the study. The measurement error computed with Dahlberg&apos;s formula was 0.2&#176;. Seven cases had planned (target setup) mandibular incisor uprighting (ccr), and five cases had proclination (clockwise rotation). There was no statistical difference (p &gt; 0.05) between planned incisor rotations of the target setup and achieved incisor rotations at the day of debonding. The overall mean difference was 2.2&#176; &#177; 1.0&#176;.
Conclusions:
The Incognito-Herbst combination is the first Herbst device with full control over mandibular incisor movement. Using this system, anchorage loss or anchorage gain is independent of the Herbst treatment. It depends only on the planned tooth position of the individual target setup.</description>
        <link>http://www.head-face-med.com/content/6/1/3</link>
                <dc:creator>Dirk Wiechmann</dc:creator>
                <dc:creator>Rainer Schwestka-Polly</dc:creator>
                <dc:creator>Hans Pancherz</dc:creator>
                <dc:creator>Ariane Hohoff</dc:creator>
                <dc:source>Head &amp; Face Medicine 2010, 6:3</dc:source>
        <dc:date>2010-03-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-6-3</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-03-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/6/1/2">
        <title>Correlation between stress, stress-coping and current sleep bruxism</title>
        <description>Background:
Stress is discussed as a potential factor in the development of sleep bruxism (SB). The aim of this study was to investigate whether specific stress-factors correlate with SB-activity.
Methods:
Sixty-nine subjects, of which 48 were SB-patients, completed three German questionnaires assessing different stress-parameters and stress-coping-strategies: Short questionnaire for recognition of stress-factors (Kurzer Fragebogen zur Erfassung von Belastungen, KFB), Questionnaire for recuperation and strain (Erholungs-Belastungs-Fragebogen, EBF-24 A/3) and the stress-coping questionnaire (Stressverarbeitungsfragebogen-78, SVF-78). The diagnosis of SB was based on the clinical criteria of the American Academy of Sleep Medicine (AASM). The degree of SB-activity was measured by the Bruxcore-Bruxism-Monitoring-Device (BBMD, Bruxcore, Boston, USA), worn for five consecutive nights and analyzed using a computer-based method. Non-parametric Spearman correlation coefficients, rho, were calculated between the psychometric data and the amount of SB-activity measured by a pixel score of the BBMD.
Results:
Significant correlations were found for &apos;daily problems&apos; (r = 0.461, p &lt; 0.01), &apos;trouble at work&apos; (r = 0.293), &apos;fatigue&apos; (r = 0.288), &apos;physical problems&apos; (r = 0.288) and the coping-strategy &apos;escape&apos; (r = 0.295) (all p &lt; 0.05).
Conclusions:
Within the limitations of this study it could be shown that subjects with high SB-activity tend to feel more stressed at work and in their daily life, which in turn might influence their physical state. These subjects also seem to deal with stress in a negative way. However, due to the rather low to almost moderate correlation coefficients and the descriptive character of the study, further investigations are necessary to examine a possible causal relationship.</description>
        <link>http://www.head-face-med.com/content/6/1/2</link>
                <dc:creator>Maria Giraki</dc:creator>
                <dc:creator>Christine Schneider</dc:creator>
                <dc:creator>Ralf Schafer</dc:creator>
                <dc:creator>Preeti Singh</dc:creator>
                <dc:creator>Matthias Franz</dc:creator>
                <dc:creator>Wolfgang Raab</dc:creator>
                <dc:creator>Michelle Ommerborn</dc:creator>
                <dc:source>Head &amp; Face Medicine 2010, 6:2</dc:source>
        <dc:date>2010-03-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-6-2</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-03-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/6/1/1">
        <title>Diseases of the salivary glands in infants and adolescents</title>
        <description>Background:
Diseases of the salivary glands are rare in infants and children (with the exception of diseases such as parotitis epidemica and cytomegaly) and the therapeutic regimen differs from that in adults. It is therefore all the more important to gain exact and extensive insight into general and special aspects of pathological changes of the salivary glands in these age groups. Etiology and pathogenesis of these entities is still not yet fully known for the age group in question so that general rules for treatment, based on clinical experience, cannot be given, particularly in view of the small number of cases of the different diseases. Swellings of the salivary glands may be caused by acute and chronic inflammatory processes, by autoimmune diseases, by duct translocation due to sialolithiasis, and by tumors of varying dignity. Clinical examination and diagnosis has also to differentiate between salivary gland cysts and inflammation or tumors.
Conclusion:
Salivary gland diseases are rare in childhood and adolescence. Their pattern of incidence differs very much from that of adults. Acute and chronic sialadenitis not responding to conservative treatment requires an appropriate surgical approach. The rareness of salivary gland tumors is particularly true for the malignant parotid tumors which are more frequent in juvenile patients, a fact that has to be considered in diagnosis and therapy.</description>
        <link>http://www.head-face-med.com/content/6/1/1</link>
                <dc:creator>Maik Ellies</dc:creator>
                <dc:creator>Rainer Laskawi</dc:creator>
                <dc:source>Head &amp; Face Medicine 2010, 6:1</dc:source>
        <dc:date>2010-02-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-6-1</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-02-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/27">
        <title>Comparative analysis of slot dimension in lingual bracket systems</title>
        <description>Background:
Orthodontic treatment with fixed appliances requires - among others - the correct clinical expression of torque, which depends on the precise fitting of archwire and slot. Especially in the lingual technique torque problems become clinically more evident than in labial appliances also with respect to the vertical alignment of teeth due to different distances from the center of resistance. The purpose of the present study was to compare the preciseness of slot dimensions of different lingual bracket systems.
Methods:
Three lingual bracket systems were included in the study (7th Generation and STb, Ormco, Glendora, CA, USA; Incognito, TOP-Service/3 M Unitek, Monrovia, CA, USA). Non destructive analysis of vertical slot dimensions was performed using precision pin gauges (Azurea, Belprahon, Switzerland) that were tapered in increments of 0.002 mm (0.00008 inch). The sizes of 240 incisor and canine brackets were measured per system (total: 720). Data were compared using one-way ANOVA. A p-value &lt; 0.05 was considered statistically significant.
Results:
Average slot dimensions were 0.467 mm &#177; 0.007 mm (0.0184 inch &#177; 0.0003 inch) for the 7th Generation bracket system, 0.466 mm &#177; 0.004 mm (0.0183 inch &#177; 0.0001) inch for the STb bracket system and 0.459 mm &#177; 0.004 mm (0.0181 inch &#177; 0.0001) inch for the Incognito bracket system. Differences between systems were statistically significant (p &lt; 0.05).
Conclusions:
The analyzed bracket systems for lingual treatment exhibited significant differences in slot dimension that will clinically result in torque play. These aspects must be considered in lingual orthodontic treatment.</description>
        <link>http://www.head-face-med.com/content/5/1/27</link>
                <dc:creator>Anton Demling</dc:creator>
                <dc:creator>Marc Dittmer</dc:creator>
                <dc:creator>Rainer Schwestka-Polly</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:27</dc:source>
        <dc:date>2009-12-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-27</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>27</prism:startingPage>
        <prism:publicationDate>2009-12-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/26">
        <title>Upper  eyelid  reconstruction: a short report of an eyelid defect following a thermal burn</title>
        <description>While the principles of eyelid reconstruction are well-established, achieving good functional and aesthetic reconstruction remains challenging.This communication presents a technique that we used on a young patient with an eyelid defect following a thermal burn. The patient was operated on to reconstruct the entire upper eyelid using, as a posterior lamella, a mucochondrial autologous graft taken from the ala of the nose as a tarsus and conjunctiva substitutes that were sutured to the Elevator palpebrae superioris aponeurosis and muscle. On the other hand, to reconstruct the anterior lamella, which consists of skin and muscle, the surgeons used a myocutaneous temporal flap taken from the region immediately lateral to the external canthus of the palpebral region, and which, after being isolated following a drawing of the upper eyelid to be reconstructed, was rotated and then sutured to the posterior lamella using the orbicularis oculi muscle as a pedicle.</description>
        <link>http://www.head-face-med.com/content/5/1/26</link>
                <dc:creator>Francesco Inchingolo</dc:creator>
                <dc:creator>Marco Tatullo</dc:creator>
                <dc:creator>Fabio Abenavoli</dc:creator>
                <dc:creator>Massimo Marrelli</dc:creator>
                <dc:creator>Alessio Inchingolo</dc:creator>
                <dc:creator>Roberto Corelli</dc:creator>
                <dc:creator>Angelo Inchingolo</dc:creator>
                <dc:creator>Gianna Dipalma</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:26</dc:source>
        <dc:date>2009-11-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-26</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2009-11-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/25">
        <title>Desmoplastic fibroma of the mandible, review of the literature and presentation of a rare case </title>
        <description>Desmoplastic fibroma (DF) is a rare, benign but locally aggressive, intraosseous lesion with a high tendency of local recurrence. In this report the actual literature is reviewed regarding epidemiological data, pathology, clinical diagnostic criterias, therapy and prognosis. Moreover, a report of an interesting case is included localized in the mandibular corpus.</description>
        <link>http://www.head-face-med.com/content/5/1/25</link>
                <dc:creator>Michael Schneider</dc:creator>
                <dc:creator>Andre Zimmermann</dc:creator>
                <dc:creator>Rita Depprich</dc:creator>
                <dc:creator>Norbert Kubler</dc:creator>
                <dc:creator>Rainer Engers</dc:creator>
                <dc:creator>Christian Naujoks</dc:creator>
                <dc:creator>Jorg Handschel</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:25</dc:source>
        <dc:date>2009-11-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-25</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2009-11-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/24">
        <title>Solitary submucous neurofibroma of the mandible: review of the literature and report of a rare case</title>
        <description>Solitary neurofibroma is a rare benign non-odontogenic tumor. Particularly in the oral cavity, neurogenic tumors are rare, especially if they are malignant. Neurofibromas may present either as solitary lesions or as part of the generalised syndrome of neurofibromatosis or von Recklinghausen&apos;s disease of the skin. Clinically, oral neurofibromas usually appear as pediculated or sessile nodules, with slow growth and mostly without pain. The diagnosis can be confirmed by histological examination. Neurofibromas are immunopositive for the S-100 protein, indicating its neural origin. Treatment is surgical and the prognosis is excellent. For illustration a rare case of a solitary neurofibroma in the mandible is presented.</description>
        <link>http://www.head-face-med.com/content/5/1/24</link>
                <dc:creator>Rita Depprich</dc:creator>
                <dc:creator>Daman Singh</dc:creator>
                <dc:creator>Petra Reinecke</dc:creator>
                <dc:creator>Norbert Kubler</dc:creator>
                <dc:creator>Jorg Handschel</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:24</dc:source>
        <dc:date>2009-11-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-24</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2009-11-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/23">
        <title>In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives</title>
        <description>Background:
Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration.Materials and methodsThe aim of this study was to evaluate the proliferative activity of human osteogenic cells after incubation over a period of seven days with commercial BSM of various origin and chemical composition. Special focus was placed on the potential additional benefit of EMD on cellular proliferation.
Results:
Except for PerioGlas&#174;, osteogenic cell proliferation was significantly promoted by the investigated BSM. The application of EMD alone also resulted in significantly increased cellular proliferation. However, a combination of BSM and EMD resulted in only a moderate additional enhancement of osteogenic cell proliferation.
Conclusion:
The application of most BSM, as well as the exclusive application of EMD demonstrated a positive impact on the proliferation of human osteogenic cells in vitro. In order to increase the benefit from substrate combination (BSM + EMD), further studies on the interactions between BSM and EMD are needed.</description>
        <link>http://www.head-face-med.com/content/5/1/23</link>
                <dc:creator>Christoph Reichert</dc:creator>
                <dc:creator>Bilal Al-Nawas</dc:creator>
                <dc:creator>Ralf Smeets</dc:creator>
                <dc:creator>Adrian Kasaj</dc:creator>
                <dc:creator>Werner Gotz</dc:creator>
                <dc:creator>Marcus Klein</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:23</dc:source>
        <dc:date>2009-11-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-23</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2009-11-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/22">
        <title>The nature of fibrous dysplasia.</title>
        <description>Fibrous dysplasia has been regarded as a developmental skeletal disorder characterized by replacement of normal bone with benign cellular fibrous connective tissue. It has now become evident that fibrous dysplasia is a genetic disease caused by somatic activating mutation of the Gs&#945; subunit of G protein-coupled receptor resulting in upregulation of cAMP. This leads to defects in differentiation of osteoblasts with subsequent production of abnormal bone in an abundant fibrous stroma. In addition there is an increased production of IL-6 by mutated stromal fibrous dysplastic cells that induce osteoclastic bone resorption.</description>
        <link>http://www.head-face-med.com/content/5/1/22</link>
                <dc:creator>Liviu Feller</dc:creator>
                <dc:creator>Neil Wood</dc:creator>
                <dc:creator>Razia Khammissa</dc:creator>
                <dc:creator>Johan Lemmer</dc:creator>
                <dc:creator>Erich Raubenheimer</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:22</dc:source>
        <dc:date>2009-11-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-22</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2009-11-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.head-face-med.com/content/5/1/21">
        <title>Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
</title>
        <description>Background:
Methylergonovine is an ergot alkaloid widely used in postpartum women. It is also an active metabolite of methysergide and previous studies suggest that it could be effective against refractory headache and cluster headache. The purpose of the present study was to assess the potential therapeutic effectiveness of methylergonovine in the emergency treatment of severe migraine.
Methods:
One hundred and twenty five female patients with migraine attending the emergency department received 0.15 mg of methylergonovine intravenously. Pain intensity, heart rate, blood pressure, and methylergonovine side effects were checked 5, 10, 15, 30 and 60 minutes after drug administration. An additional 0.075 mg dose of methylergonovine was administered to those patients who did not experienced relevant pain relief 15 minutes after dosing.
Results:
Pain intensity decreased markedly from the first minutes after dosing, the 74.4% of patients being pain free at 60 minutes. Only seven patients required an additional dose of methylergonovine. Nausea and vomiting were the most relevant side effects related with methylergonovine administration (84% of patients). A substantial decrease (10 to 25 mmHg) in systolic blood pressure values was observed in 56% of the patients. A significant correlation (p &lt; 0.0001) was found between the decrease in pain intensity and the reduction of systolic blood pressure.
Conclusion:
Although limited by the non-controlled design of the study, our data suggest that intravenous methylergonovine can be an effective and safe drug in the management of severe migraine attacks in the emergency room.</description>
        <link>http://www.head-face-med.com/content/5/1/21</link>
                <dc:creator>Alfredo Nino-Maldonado</dc:creator>
                <dc:creator>Gary Caballero-Garcia</dc:creator>
                <dc:creator>Wilfrido Mercado-Bochero</dc:creator>
                <dc:creator>Fernando Rico-Villademoros</dc:creator>
                <dc:creator>Elena Calandre</dc:creator>
                <dc:source>Head &amp; Face Medicine 2009, 5:21</dc:source>
        <dc:date>2009-11-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-160X-5-21</dc:identifier>
        <prism:publicationName>Head &amp; Face Medicine</prism:publicationName>
        <prism:issn>1746-160X</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2009-11-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
